TickerFactsScreenerDevelopers

BIOREGENX, INC. (BRGX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2021: -$119.5K2022: -$64.7K2023: -$1.52M2024: -$324.1K2025: $39.0K$39.0K
2021Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$39.0K+112.0%
2024-$324.1K+78.6%
2023-$1.52M-2243.4%
2022-$64.7K+45.9%
2021-$119.5K—